R&D and Business Tracker for Bispecific Antibodies

Publisher: La Merie Publishing
Format: PDF and Online
Type: Monthly PDF by e-mail and Online
Product Code: LMPE0004
Release Date: September of 2016

1,200.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

R&D and Business Tracker for Bispecific Antibodies- a monthly update service

This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf format by e-mail straight to your desk and provides online access to La Merie Publishing‘s R&D database for the subject field of the service during the one-year subscription period. Credentials to access the online database will be sent by e-mail within 24 hours after purchase.

This product consists of:

  • 12 monthly update reports in pdf format delivered by e-mail; and
  • online access to Bispecific Antibody R&D database during the 1-year subscription period.

The R&D and Business Tracker for Bispecific Antibodies covers;

  • T-Cell redirecting bispecific cancer antibodies
  • NK cell redirecting bispecific cancer antibodies
  • Bispecific immuno-oncology antibodies
  • Bispecific tumor antigens targeted cancer antibodies
  • Bispecific antibodies for inflammatory & autoimmune diseases
  • Bispecific antibodies for cardiometabolic, infectious, neurologic, ophthalmic or pulmonary diseases

Download our pilot issue as a sample of the monthly pdf update report: R&D and Business Tracker sample issue for Bispecific Antibodies

The monthly update report about Bispecific Antibodies contains:

R&D and Technology Tracker

  • Pipeline changes
  • Regulatory news
  • Technology validations
  • Manufacturing news

Business Tracker for:

  • Company updates
  • Collaboration
  • Licensing
  • Merger & acquisitions
  • Financing

Clinical Trial Tracker
Scientific Publication Tracker
Featured Bispecific Antibody or Technology Profile
Featured Company Profile
Featured Target or Technology Pipeline

Methodology:
Information released during the previous month is retrieved from a variety of sources including corporate press releases and statements, quarterly company business reports, SEC filings, company presentations, company websites, interviews, webcasts, journal articles, scientific abstracts and reviews, relevant scientific meetings, clinical trial databases, and La Merie Publishing’s proprietary database. Relevant information is presented in textual and tabular formats with disclosure of scientific references or by a hyperlink leading to the source of information.

Customized Update Service:
The above described information service represents our standard module. At an incremental cost, the service can be exclusively widened and customized to specific client needs, e.g. preparation of a preferred presentation format, inclusion of a watch list for tracking, executive summary etc.

Contact us at publishing@lamerie.com to discuss your needs and our ideas of fulfilling them.


The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top